ScreenerHero

JAGX Jaguar Health, Inc.

NAS · US · Healthcare · Biotechnology · jaguar.health
4.730USD+29.23%Mkt Cap: 9.20M $P/E: —

Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal He…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap9.20M USD
Enterprise Value14.08M USD
Revenue (TTM)27.82M USD
Gross Profit7.74M USD
Net Income (TTM)-53.43M USD
Revenue/Share1240.63 USD
Last Price4.730 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees47
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.64
PEG—
EV/EBITDA-0.61
EV/Revenue0.51
P/S0.26
P/B2.69
EPS (TTM)-4012.65
EPS (Forward)-5.68
52W Range
0.29545% of range85.40
52W High85.40 USD
52W Low0.2954 USD
Profitability
Gross Margin67.21%
Oper. Margin-620.16%
EBITDA Margin-83.38%
Profit Margin-464.20%
ROE309.06%
ROA-139.43%
Growth
Revenue Growth-58.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-23.69M USD
CapEx (TTM)41.00K USD
FCF Margin-6.39%
FCF Yield-19.32%
Net Debt12.86M USD
Net Debt/EBITDA-0.55
Balance Sheet
Debt/Equity-2.52
Current Ratio0.74
Quick Ratio0.17
Book Value/Sh1.36 USD
Cash/Share10.99 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 7, 2019
Splits
Last Split1:15
Split DateSep 17, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.95M
Float289.42K
Insiders2.04%
Institutions0.02%
Short Interest
Short Ratio0.7d
Short % Float5.01%
Short % Out.5.01%
Shares Short21.74K
Short (prev mo.)7.80K
Technical
SMA 5010.69 (-55.7%)
SMA 200174.48 (-97.3%)
Beta-0.06
S&P 52W Chg14.58%
Avg Vol (30d)3.14M
Avg Vol (10d)7.59M
Technical Indicators
RSI (14)50.3
MACD0.8828
MACD Signal1.3817
MACD Hist.-0.4989
BB Upper19.84 USD
BB Middle4.910 USD
BB Lower-10.0145 USD
BB Width607.89%
ATR (14)3.492 USD
Vol Ratio (20d)4.12x